ATS 2018 International Conference

The Potential for RORgamma Antagonists to Treat A Sub-Population of Severe Asthma: A Translational Approach

Location: PRE-FUNCTION 5-6

Session Type: Mini Symposium

Wednesday

May

9:15 AM

9:30 AM

Speaker(s)/Author(s)

Joseph Wahle

PhD
Boehringer Ingelheim Pharmaceuticals, Inc.

Katherina Sewald

Dr. rer. nat.
Fraunhofer ITEM;Fraunhofer ITEM, Biomedical Research in Endstage and Obstructive Lung (BREATH), Member of the German;Fraunhofer ITEM, Biomedical Research in Endstage and Obstructive Lung Disease Hanno

Dorothy De Sousa

PhD
Boehringer Ingelheim (Canada) Ltd./Ltée

Katrin Fundel-Clemens

PhD
Boehringer Ingelheim Pharma GmbH & Co. KG

Armin Braun

Prof. Dr. rer. nat.
Fraunhofer ITEM;Fraunhofer ITEM, Biomedical Research in Endstage and Obstructive Lung (BREATH), Member of the German;Fraunhofer ITEM, Biomedical Research in Endstage and Obstructive Lung Disease Hanno